A new study found that the PD-L1 inhibitor nivolumab is effective in mesothelioma. It was tested on patients and showed that it could be a safe and effective treatment for those whose first line treatments have failed. Nivolumab is an immunotherapy drug that helps the immune system fight cancer cells.[…]
Novel Treatments & Drugs
Curcumin Could Soon Be Used to Treat Mesothelioma
Curcumin could soon be used to treat mesothelioma patients. It is a natural compound found in turmeric, a spice commonly found in Asian dishes. This natural compound has been used as an anti-inflammatory alongside other treatments, but it could soon be used as a standard mesothelioma treatment, which is what[…]
Two Substances Used to Treat Different Cancers Could Potentially Help Mesothelioma Patients
Two drugs could soon be used together to treat the most aggressive form of mesothelioma. Mesothelioma is an incurable cancer with very few options for treatment. Chemotherapy and immunotherapy can be used to extend patients’ lives, but they cannot be used to completely cure the disease. There is still hope[…]
There is a Possible New Way to Diagnose Pleural Mesothelioma
Researchers have possibly found a less invasive way to diagnose pleural mesothelioma. By looking at the patient’s medical history and using CT scans, researchers at the Universite Laval in Quebec have found that imaging technology can be used potentially to benefit very sick patients. Doctors have never been able to[…]
First FDA Approved Mesothelioma Treatment in 15 Years to be Used Soon
A new cancer treatment using electricity has been approved for use in mesothelioma patients. The NovoTTF-100L uses Tumor Treating Fields, which are electric signals tuned to a specific frequency, to disrupt cancerous cell division. The fields are applied to the patient with adhesive bandages and are used for at least[…]
MicroRNA Could be used to Quickly Diagnose Mesothelioma
Biomarkers are measureable substances that indicate if someone has a disease. Doctors and researchers are able to find different substances within a person’s body and deduce that the person has a specific type of cancer. Researchers have found a relatively new biomarker called microRNA, which could possibly be used to[…]
Phase I Clinical Trial Yields Positive Results In Latest Immunotherapy Treatment
The immune system is the body’s first line of defense when fighting off any illness, attacking foreign organisms or other substances that may harm or threaten the over health of the body. When the immune system is compromised, the body is unable to fight infections and becomes weak as the[…]
Potential New Treatment Acts as a Sealant for Pleural Mesothelioma Tumors
Pleural mesothelioma, caused by exposure to asbestos is a rare cancer – only 3,000 cases are diagnosed in the U.S. each year – but it is highly aggressive. There is no cure for plural mesothelioma but findings published in the Journal of Thoracic and Cardiovascular Surgery reveal that a new[…]
First FDA Approved Treatment for Mesothelioma in 15 Years
In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes[…]
Currently Recruiting: Mesothelioma Clinical Trials
When it comes to effective mesothelioma treatments, options are unfortunately limited. There is no cure for mesothelioma and first line chemotherapy treatment Alimta, is no guarantee. Many who are suffering from mesothelioma, who have found little or no comfort in traditional treatments, may turn to clinical trials for hope. Through[…]
